Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain

N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain

US Patent 8143408 · Granted Mar 27, 2012

Estimated economic value: $3,525,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds2019
Compounds and their use as BACE inhibitors2019
Compounds and their use as BACE inhibitors2019
Imidazo[1,2-B][1,2,4]triazine derivatives as antiparasitic agents2018
Compounds and their use as BACE inhibitors2018
Compounds and their use as BACE inhibitors2018
Triazole compounds and their use as gamma secretase modulators2017
Triazole compounds and their use as gamma secretase modulators2017
Pyrimidine compounds and their use as gamma secretase modulators2016
Compounds and their use as BACE inhibitors2016
Compounds and their use as BACE inhibitors2016
2H-imidazol-4-amine compounds and their use as BACE inhibitors2015